#mots-c

2 stories

Regulatory April 8, 2026 · View digest

UK MHRA Probes Peptide Clinics Over Unlawful BPC-157 and MOTS-C Health Claims

The UK's MHRA is investigating peptide clinics promoting BPC-157, MOTS-C, and Cortexin with unproven claims. Making medicinal claims classifies these products as medicines under UK law.

Regulatory March 27, 2026 · View digest

RFK Jr. Signals FDA Will Deregulate ~14 Peptides Including BPC-157 and Ipamorelin

Health Secretary Kennedy announced on Joe Rogan's podcast that the FDA will soon reclassify about 14 peptides currently restricted from compounding pharmacies, aiming to curb gray-market sourcing.